Inflammatory lipids are involved in neurotrauma. They are key players in regulating the brain, spinal cord and immune responses to injury and thus in modulating the outcome of central nervous system (CNS) damage. We will investigate how bioactive inflammatory lipids, released during trauma, modulate neural response to injury and regeneration, by assessing their roles on central nervous system responses to injury.
Cellular Mechanisms Underlying Neurodegenerative Disease And The Neuronal Response To Trauma
Funder
National Health and Medical Research Council
Funding Amount
$406,264.00
Summary
Brain and spinal cord injury are major causes of death and disability, with degenerative diseases similarly affecting large proportions of the population. The singular objective of my research proposal is to increase our understanding of the molecular and cellular processes by which nerve cells respond to trauma and diseases such as Alzheimer’s and Parkinson’s, and to identify new therapeutic approaches aimed at encouraging the repair of damaged cells.
Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15), CCAAT/enhancer Binding Protein Delta (CEBPD) And Neuroinflammtion
Funder
National Health and Medical Research Council
Funding Amount
$459,270.00
Summary
I will develop new therapies for multiple sclerosis and spinal cord injury. I will also evaluate diagnostic and therapeutic uses for macrophage inhibitory cytokine-1 (MIC-1/GDF15) that was discovered in Australia. I will confirm its use in screening for bowel cancer. Also, I will look at using it in the indigenous and wider Australian community to improve health and close the gap in life expectancy. Finally, I will conduct trials of MIC-1/GDF15 therapy of obesity and inflammation.